首页> 外文OA文献 >Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
【2h】

Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.

机译:美金刚和MK-801对NMDA诱导的培养神经元电流以及大鼠海马切片CA1区突触传递和LTP的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effects of the uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, memantine (1-amino-3,5-dimethyladamantane) and MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzocyclo-hepten-5,10-imin e maleate) were compared on synaptic transmission and long-term potentiation (LTP) in hippocampal slices and on NMDA-induced currents in cultured superior collicular neurones. 2. Memantine (10-100 microM) reversibly reduced, but did not abolish, NMDA receptor-mediated secondary population spikes recorded in area CA1 of hippocampal slices bathed in Mg(2+)-free artificial cerebrospinal fluid. 3. Memantine (100 microM) antagonized NMDA receptor-mediated excitatory postsynaptic currents recorded in area CA1 in a strongly voltage-dependent manner i.e. depressed to 11 +/- 4% of control at -35 mV and 95 +/- 5% of control at +40 mV (n = 9), with no apparent effect on response kinetics. 4. The effects of MK-801 and memantine on the induction of LTP were assessed after prolonged pre-incubations with these antagonists. When present for 6.6 +/- 0.4 h prior to tetanic stimulation, memantine blocked the induction of LTP with an IC50 of 11.6 +/- 0.53 microM. By comparison, similar long pre-incubations with MK-801 (6.4 +/- 0.4 h) blocked the induction of LTP with an IC50 of 0.13 +/- 0.02 microM. 5. Memantine and MK-801 reduced NMDA-induced currents in cultured superior colliculus neurones recorded at -70 mV with IC50s of 2.2 +/- 0.2 microM and 0.14 +/- 0.04 microM respectively. The effects of memantine were highly voltage-dependent and behaved as though the affinity decreased epsilon fold per 50 mV of depolarization (apparent delta = 0.71). In contrast, under the conditions used, MK-801 appeared to be much less voltage-dependent i.e. affinity decreased epsilon fold per 329 mV of depolarization (apparent delta = 0.15). 6. Depolarizing steps from -70 mV to +50 mV in the continuous presence of memantine (10 microM) caused a rapid relief of blockade of NMDA-induced currents from 83.7 +/- 1.9% to 21.8 +/- 1.8% (n = 5). This relief was best fitted by a double exponential function (17.2 +/- 11.7 and 698 +/- 204 ms), the faster component of which was most pronounced. 7. In conclusion, whereas MK-801 is equipotent in blocking NMDA-induced currents (at - 70 mV) and the induction of LTP, memantine is relatively less potent in blocking the induction of LTP. This is due to its rapid relief of blockade upon depolarization; a property which might explain its promising clinical profile in the treatment of chronic neurodegenerative diseases.
机译:非竞争性N-甲基-D-天冬氨酸(NMDA)受体拮抗剂,美金刚(1-氨基-3,5-二甲基金刚烷)和MK-801((+)-5-甲基-10,11-dihydro-5H -dibenzocyclo-hepten-5,10-imin e maleate)在海马切片中的突触传递和长期增强(LTP)以及在培养的上层胶状神经元中NMDA诱导的电流上进行了比较。 2.美金刚胺(10-100 microM)可逆地减少,但没有消除,NMDA受体介导的次级种群高峰记录在沐浴在不含Mg(2+)的人工脑脊髓液中的海马切片CA1区。 3.以强烈的电压依赖性方式在区域CA1中记录的美金刚胺(100 microM)拮抗NMDA受体介导的兴奋性突触后突触电流,即在-35 mV时压低至对照的11 +/- 4%,在对照的95 +/- 5%下+40 mV(n = 9)时,对响应动力学没有明显影响。 4.在与这些拮抗剂长期预孵育后,评估了MK-801和美金刚对LTP的诱导作用。当在强直性刺激之前存在6.6 +/- 0.4 h时,美金刚可以阻断LTP的诱导,IC50为11.6 +/- 0.53 microM。相比之下,使用MK-801进行的类似长时间预孵育(6.4 +/- 0.4小时)以0.13 +/- 0.02 microM的IC50阻断了LTP的诱导。 5.美金刚和MK-801降低了在-70 mV记录的培养的上丘神经元中NMDA诱导的电流,IC50分别为2.2 +/- 0.2 microM和0.14 +/- 0.04 microM。美金刚的作用高度依赖电压,并且表现为每50 mV去极化时亲和力降低ε倍(表观δ= 0.71)。相反,在所使用的条件下,MK-801似乎对电压的依赖性小得多,即每329 mV去极化的亲和力降低了ε倍(表观δ= 0.15)。 6.在持续存在美金刚(10 microM)的情况下,从-70 mV到+50 mV的去极化步骤使NMDA感应电流的阻滞从83.7 +/- 1.9%迅速缓解到21.8 +/- 1.8%(n = 5)。最好通过双指数函数(17.2 +/- 11.7和698 +/- 204 ms)来拟合此浮雕,该函数的较快成分最为明显。 7.总之,尽管MK-801在阻断NMDA诱导的电流(在-70 mV)和LTP的诱导上是等效的,但美金刚在阻断LTP的诱导上相对较弱。这是由于其迅速消除了去极化时的封锁。该特性可以解释其在治疗慢性神经退行性疾病中的临床前景。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号